(Q79838169)
Statements
Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b (English)
Krzysztof Selmaj
David H Miller
Chris Polman
Ludwig Kappos
Mark S Freedman
Gilles Edan
Hans-Peter Hartung
Xavier Montalbán
Frederick Barkhof
Bernard M J Uitdehaag
Susanne Dahms
Lars Bauer
Christoph Pohl
Rupert Sandbrink
BENEFIT investigators
15 November 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference